Role of important protein improves understanding of autoimmune diseases

22 Mar 2016, 4:59 p.m.

Genetic analyser for BRC

Researchers – led by Great Ormond Street BRC-supported Professor Tessa Crompton in collaboration with the Paediatric Department at Oxford University – have identified the role of a key protein in normal development of the thymus, an important organ of the immune system. The protein, known as Sonic hedgehog (SHH), is one of a few factors that regulate thymic epilthelial cell (TEC) differentiation and lineage choice. These findings contribute to our understanding of human autoimmune diseases and will inform strategies to replace thymus function in athymic children.

TECs are an essential component of the thymic stroma and are required to support T cell development. Two broad categories of TEC exist; medullary TECs, which are essential for the induction of tolerance to self, and cortical TECs, which are essential for T cell fate specification and T cell receptor repertoire selection. Researchers used both adult and foetal TECs to show that SHH regulates medullary TEC differentiation and function, with the potential to alter central tolerance.

These findings are important to our understanding of immunity, autoimmunity and immunodeficiency. In the future it will be important to assess the effects of SHH signalling on the induction and severity of human autoimmune diseases.

These findings were published in the Journal of Autoimmunity.

Professor Waseem Qasim named in list of leading global health leaders

Professor Waseem Qasim, Consultant at GOSH and Professor of Cell and Gene Therapy at University College London has been named in TIME magazine’s 2026 TIME100 Health List of the World’s Most Influential Leaders in Health.

Alyssa Tapley named in list of leading global health leaders

GOSH patient, Alyssa Tapley, 17 from Leicester, has been named in TIME’S 2026 TIME100 Health List of the World’s Most Influential Leaders in Health.

GOSH joins partnership to boost early diagnosis and deliver better treatments

GOSH is partnering with LifeArc to set up KidsRare - a new initiative to help deliver more tests and treatments for children living with a rare disease.

How linked health and education data is changing what we know about children with neurodisability

Children with neurodisability often have complex health and educational needs, but population level data on long term outcomes remains limited. New research from GOS-ICH addresses this gap using one of the largest national birth cohorts to date.